Shots:

• J&J’s Ethicon has launched VISTASEAL Fibrin Sealant (Human) for providing aid to surgeons to manage bleeding during surgery and is designed applied on the bleeding site to quickly seal off and control excessive bleeding during open surgeries or minimally invasive procedures
• VISTASEAL was developed by Grifols and licensed it to Ethicon under a strategic collaboration which combines Ethicon’s expertise in developing device technology with Grifols’ ability to produce critical plasma-based therapies
• VISTASEAL comprises the combination of fibrinogen and thrombin- clotting proteins found in human plasma- available in pre-filled syringes and has demonstrated a lower overall hemostatic retreatment rate (0.9%-7.8%) vs standard treatments (8.0%-16.7%)

Click here to­ read full press release/ article | Ref: JNJ Image: JNJ Medical Device